Risk grade updatedRisk gradeEvidence verified
17 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade C.Business profile
Evexys Biotech Oy
Evexys Biotech Oy's registered office is Esbo. It is a limited company. The company was established on 2015-10-26. It operates in the industry of wholesale of pharmaceutical goods.
Business ID 2719085-2ValidUnclaimed company profile
Trusted core data
Public company details from the trade register.
- Business ID
- 2719085-2
- Sector
- Wholesale of pharmaceutical goods
- Municipality
- Esbo
- Company form
- Limited company
- Registration date
- 2015-10-26
- Business ID registration date
- 2015-10-20
- Business status
- Valid
- Profile ownership
- Unclaimed company profile
Contact and location summary
Visiting address: Ajokoirantie 9 C, 02940, Esbo
About Evexys Biotech Oy
Financial position and key figures for the company.
Evexys Biotech Oy's location municipality is Esbo. It is a limited company. The company was established on 2015-10-26. It operates in the industry of wholesale of pharmaceutical goods. Based on the latest retained statement, revenue growth was not currently available, operating margin was not currently available, and equity ratio was -31668.6%.
Financial highlights
Key figures from the latest financial period.
Latest financial period
2025-12-31
4
3
PRH/XBRL financial statement
Derived indicators
Equity ratio-31668.6%
Balance-sheet contextLatest financial period
Cash and bank€90Previous: €166
Retained earnings-€27,716Previous: -€17,639
Equity-€28,426Previous: -€25,216
Liabilities€28,516Previous: €25,382
Current assets€90Previous: €166
Operating profit (loss) trend3 periods
-€2,941
2023-12-31
-€10,077
2024-12-31
-€3,210
2025-12-31
Profit (loss) for the financial year trend3 periods
-€2,941
2023-12-31
-€10,077
2024-12-31
-€3,210
2025-12-31
Assets trend3 periods
€300
2023-12-31
€166
2024-12-31
€90
2025-12-31
Financial ratios
Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.
Equity ratioWeak
0/100 · Declining
Current ratioNot assessable
0/100 · Trend unavailable
Operating profit marginNot assessable
0/100 · Trend unavailable
Ratio history
| Ratio | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Equity ratio | -5040.5 % | -15192.8 % | -31668.6 % |
| Current ratio | 0.84x | - | - |
| Operating profit margin | - | - | - |
Registry status and identifiers
Current registry information and identifiers based on YTJ data.
YTJ statusValid
Trade RegisterRegistered
Business ID2719085-2
EU IDFIFPRO.2719085-2
MunicipalityEsbo
Current registered entries
2015-10-26Registered in Patent and Registration Office (Trade Register)
2015-11-03Registered in Tax Administration (Tax Administration)
Risk certificate
An open-data based company stability and risk signal.
BUSINESS.fi
BUSINESS.fi Luottoluokitus
Profile-specific risk signal based on open data
Automatic gradeNot a credit decision
C
Elevated riskEvexys Biotech Oy
Grade unchangedC · new analysis 2026-10-17
39/100
Medium
Limited financial evidenceRegistry and statistics based
Financial development is mostly stable or mixed.
3 comparable periodsRevenueNot enough history
ProfitabilityNot enough history
LiquidityNot enough history
RegularBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
4 observed filings160 days after period end
149 days after period end
4 consecutive periods
Supporting factors
- Active registered status
- Long registry continuity
Risk factors to note
- Elevated industry distress context
- Sufficient structured financial metrics are not available
Automatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
5 assessmentsC
2026-10-1739/100 · v0.15
C → CC
2026-10-03 12:0839/100 · v0.14
C → C- Evidence strengthened: another PRH/XBRL statement was added to the financial series (2025-12-31).
B1
2026-09-1561/100 · v0.14
B2 → B1 · +3 points- Assessment confidence: Low → Medium.
- Evidence quality: Registry and statistical evidence → Registry and statistical evidence.
- New risk factor: Sufficient structured financial metrics are not available.
B2
2026-09-1458/100 · v0.12
Oldest retained automatic assessment in this comparisonC
2026-10-17
open-risk-grade-v0.15
The grade uses registry, industry, and regional signals because sufficient source-backed financial metrics are not available for a Tier 1 assessment.
A serious financial risk signal affects this grade. Review the profile financial indicators as well.
Risk context
When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.
Industry riskelevated
45/100
Industry context is elevated based on normalized open statistical inputs.
Age and continuityVakiintunut
80/100
The company has about 10 years of registry continuity.
Registry and status signalsSeurattava
63/100
Registry history, filing recency, and active register markings are still limited or mixed.
Events & news
Verified events and sourced external company news in one timeline.
Risk grade updatedRisk gradeEvidence verified
3 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1 → C.Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.Registry timeline
Trade register notifications shown on a timeline.
12 register eventsLatest event: 2025-04-16
Financial statements availability
Available financial statement periods and PRH source filings.
4 financial statement periodsLatest financial period: 2025-12-31
Profile source and ownership
Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.
This company profile has not been claimed yet
Evexys Biotech Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.